A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kyung Ho Song, MD, Master
Konyang University Hospital
Principal Investigator - Seong Woo Jeon, MD, PhD
Kyungpook National University Medical Center
Principal Investigator - Shiming Yang, MD, PhD
Xinqiao Hospital of Chongqing
Principal Investigator - Su Jin Hong, MD, PhD
Soonchunhyang University Buchen Hospital
Principal Investigator - Yong Chan Lee, MD, PhD
Severance Hospital, Yonsei University Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yang Shiming
Chongqing, Chongqing Municipality, China
- Soonchunhyang University Bucheon Hospital
Bucheon-si, South Korea
- Kyungpook National University Medical Center
Daegu, South Korea
- Konyang University Hospital
Daejeon, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 31 Jan 2016
- Completion
- 30 Apr 2016
- Last update posted
- 29 Apr 2016
- Registered enrollment
- 143
- Registry id
- NCT02755753
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.